Repository logo
 

Drug-resistance mechanisms and tuberculosis drugs.

Repository URI

https://www.repository.cam.ac.uk/handle/1810/247646

Repository DOI

Thumbnail Image

Files

Koser et al 2015 Lancet.pdf (299.17 KB)

Type

Article

Change log

Authors

Description

Keywords

Antitubercular Agents, Diarylquinolines, Drug Approval, Humans, Mutation, Nitroimidazoles, Oxazoles, Tuberculosis, Multidrug-Resistant

Journal Title

Lancet

Conference Name

Journal ISSN

0140-6736
1474-547X

Volume Title

385

Publisher

Elsevier

Publisher DOI

https://doi.org/10.1016/S0140-6736(14)62450-8

Rights and licensing

Attribution-NonCommercial-NoDerivs 2.0 UK: England & Wales
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-NoDerivs 2.0 UK: England & Wales
Sponsorship
Wellcome Trust (098600/Z/12/Z)
This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the UK Department of Health and Wellcome Trust.

Collections

Scholarly Works - Medicine
Symplectic mapped items for data match